Has Johnathan Goree, MD received payments from drug or device companies?

Yes. Drug and device makers reported $917,117 in general payments to Johnathan Goree, MD across 787 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Johnathan Goree, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Johnathan Goree, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Johnathan Goree, MD

Anesthesiology · Little Rock, ARNPI 1760625628

Payments from drug & device makers

$917,117in general payments, 2019–2025

Across 787 payments — averaging $1165.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Saluda Medical Americas, Inc.$298K
SPR Therapeutics, Inc$256K
Abbott$162K
MML US, Inc.$150K
Stratus Medical, LLC$49K
Relievant Medsystems, Inc.$386
plus $2K from 11 others

$374in research payments, 2019–2025

Across 5 payments — averaging $74.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Saluda Medical Americas, Inc.$374

What the payments were for

Consulting fees$289,86957%
Speaking & faculty fees$121,12524%
Travel & lodging$55,07111%
Food & beverage$27,4525%
Education$19,1694%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Saluda Medical Americas, Inc.	226	$297,992
SPR Therapeutics, Inc	15	$256,173
Abbott	314	$161,936
MML US, Inc.	51	$150,068
Stratus Medical, LLC	149	$48,839
Relievant Medsystems, Inc.	8	$386
Nevro Corp.	6	$361
Nalu Medical, Inc.	3	$289
Boston Scientific	4	$288
Brixton Biosciences, Inc.	1	$239
Stryker	2	$156
Averitas Pharma Inc.	1	$124
Stimwave Technologies Incorporated	1	$117
Vertos Medical, Inc.	2	$59
Globus Medical	1	$39
Tersera Therapeutics LLC	2	$32
Medtronic	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Evoke$211,984
PROCLAIM$125,765
Evoke SCS$82,720
Nimbus$32,504
IonicRF Generator$13,125
Proclaim DRG IPG$11,281
Proclaim IPG$1,793
ReActiv8$1,393
Infinity DBS Pulse Generators$1,000
Axium$710
Axium INS DRG IPG$669
Proclaim Family of SCS IPGs$601
PRODIGY$419
Neural Ice$239
Senza II$221
Protege Family of SCS IPGs$152
IVS - MULTIGEN 2RF$150
Nalu Neurostimulation System$146
Qutenza$124
StimQ Receiver Stimulator Kit Channel A US w Receiver$117

How this compares

$917,117 in reported general payments places this provider in the 95th percentile of 300 anesthesiology providers in Arkansas.

See all anesthesiology providers in Arkansas →

Medicare billing

Part B allowed, 2024

$81,817

Medicare patients

239

Services billed

925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pregabalin	31	$3,569
Fentanyl	25	$1,968
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	30	$1,570
Gabapentin	107	$1,314
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	55	$1,003
Methadone Hcl	42	$852
Baclofen	28	$420
Tramadol Hcl	61	$385
Duloxetine Hcl	17	$325
Tizanidine Hcl	33	$300
Celecoxib	12	$268
Meloxicam	12	$48
Methocarbamol	11	$48

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Little Rock

Julius BaloghLittle Rock$245K
Michael SchmitzLittle Rock$160K
Gregory SmithLittle Rock$55K
Mohammad SiddiquiLittle Rock$37K
Brian MalkiLittle Rock$29K
Aparna JindalLittle Rock$10K
Jarna ShahLittle Rock$10K
Brian JansenLittle Rock$8K
Jaleesa JacksonLittle Rock$4K
Juan RomanLittle Rock$4K

See the full list for Arkansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →